AU9797598A - Treatment of diabetic retinopathy - Google Patents

Treatment of diabetic retinopathy

Info

Publication number
AU9797598A
AU9797598A AU97975/98A AU9797598A AU9797598A AU 9797598 A AU9797598 A AU 9797598A AU 97975/98 A AU97975/98 A AU 97975/98A AU 9797598 A AU9797598 A AU 9797598A AU 9797598 A AU9797598 A AU 9797598A
Authority
AU
Australia
Prior art keywords
treatment
diabetic retinopathy
retinopathy
diabetic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU97975/98A
Other languages
English (en)
Inventor
Louis DeSantis Jr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Alcon Vision LLC
Original Assignee
Alcon Laboratories Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alcon Laboratories Inc filed Critical Alcon Laboratories Inc
Publication of AU9797598A publication Critical patent/AU9797598A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU97975/98A 1997-11-14 1998-10-09 Treatment of diabetic retinopathy Abandoned AU9797598A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US6569497P 1997-11-14 1997-11-14
US60065694 1997-11-14
PCT/US1998/021423 WO1999025350A1 (en) 1997-11-14 1998-10-09 Treatment of diabetic retinopathy

Publications (1)

Publication Number Publication Date
AU9797598A true AU9797598A (en) 1999-06-07

Family

ID=22064483

Family Applications (1)

Application Number Title Priority Date Filing Date
AU97975/98A Abandoned AU9797598A (en) 1997-11-14 1998-10-09 Treatment of diabetic retinopathy

Country Status (4)

Country Link
AR (1) AR013749A1 (es)
AU (1) AU9797598A (es)
WO (1) WO1999025350A1 (es)
ZA (1) ZA989514B (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050009884A1 (en) * 1997-06-30 2005-01-13 Dreyer Evan B. Calcium blockers to treat proliferative retinal diseases
BRPI0513862A (pt) * 2004-07-26 2008-05-20 Allergan Inc métodos de tratar condições oftálmicas
US20070203144A1 (en) * 2006-01-17 2007-08-30 Allergan, Inc. Use of Memantine and Brimonidine to Attenuate Vitreoretinal Vascular Endothelial Growth Factor (VEGF) Protein Levels in Animals
EP2544677A4 (en) * 2010-03-08 2013-07-10 Univ Tennessee Res Foundation BETA-ADRENERGIC RECEPTOR AGONISTS AND USES THEREOF

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU4807790A (en) * 1988-12-05 1990-06-26 Houston Biotechnology Incorporated Therapeutic use of calcium entry blockers in retinal or optic nerve dysfunction
US5521215A (en) * 1989-11-07 1996-05-28 Ramot University Authority For Applied Research And Industrial Development Ltd. NMDA-blocking pharmaceuticals
US5856329A (en) * 1995-06-28 1999-01-05 Allergan Method of using (2-imidazolin-2-ylamino) quinoxalines in treating ocular neural injury
FR2738568B1 (fr) * 1995-09-08 1997-10-17 Synthelabo Derives de 4-(cycloalkyl)piperidines et 4-(cycloalkylalkyl) piperidines, leur preparation et leur application en therapeutique
EP0903144A4 (en) * 1996-04-17 2001-10-31 Sumitomo Pharma MEDICINE FOR RETINAL NEUROPATHY

Also Published As

Publication number Publication date
AR013749A1 (es) 2001-01-10
WO1999025350A1 (en) 1999-05-27
ZA989514B (en) 1999-06-15

Similar Documents

Publication Publication Date Title
AU9040098A (en) Compounds and method for the prevention and treatment of diabetic retinopathy
AU712853B2 (en) Noninvasive blood analyzer
AU9028798A (en) Method of improving drug treatment
AU2263197A (en) Diabetes therapy
AU6625896A (en) Oxygen bandage
AU1450900A (en) Methods of treatment of type 2 diabetes
AU1704499A (en) Active blood filter
AU3891299A (en) Combination therapy for treatment of depression
AUPN089295A0 (en) Treatment of diabetic neuropathy
AU2749395A (en) Medical use of bromelain
AUPP105497A0 (en) Aqueous insecticidal pour-on treatment
AUPO871397A0 (en) Improved treatment of hides
AU7595298A (en) Azolidinediones useful for the treatment of diabetes, dyslipidemia and hy pertension
AU9797598A (en) Treatment of diabetic retinopathy
AU6829696A (en) Treatment of solutions
AU1181897A (en) Medical use of proteases
AU1712395A (en) Medical application of bromelain
AU4107797A (en) Compounds for the treatment and prevention of diabetes
AU1645599A (en) Human matrilin-3
AU6034298A (en) Two human homologues of galectin-5
AU3190595A (en) Corneal therapeutic agent
AU4124497A (en) Treatment of diabetes
AU696976B2 (en) Effluent treatment
AU8557598A (en) Treatment of fluids
AU5576498A (en) Prophylactic or therapeutic agent for diabetic complication

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase